633 related articles for article (PubMed ID: 18382329)
1. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
2. System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells.
Kim DK; Kim IJ; Hwang S; Kook JH; Lee MC; Shin BA; Bae CS; Yoon JH; Ahn SG; Kim SA; Kanai Y; Endou H; Kim JK
Neurosci Res; 2004 Dec; 50(4):437-46. PubMed ID: 15567481
[TBL] [Abstract][Full Text] [Related]
3. System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line.
Yamauchi K; Sakurai H; Kimura T; Wiriyasermkul P; Nagamori S; Kanai Y; Kohno N
Cancer Lett; 2009 Apr; 276(1):95-101. PubMed ID: 19058911
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M
Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406
[TBL] [Abstract][Full Text] [Related]
5. L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.
Nawashiro H; Otani N; Shinomiya N; Fukui S; Ooigawa H; Shima K; Matsuo H; Kanai Y; Endou H
Int J Cancer; 2006 Aug; 119(3):484-92. PubMed ID: 16496379
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional characterization of the system L amino acid transporter in KB human oral epidermoid carcinoma cells.
Yoon JH; Kim YB; Kim MS; Park JC; Kook JK; Jung HM; Kim SG; Yoo H; Ko YM; Lee SH; Kim BY; Chun HS; Kanai Y; Endou H; Kim DK
Cancer Lett; 2004 Mar; 205(2):215-26. PubMed ID: 15036654
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor stimulates LAT1 gene expression in vascular smooth muscle: role in cell growth.
Liu XM; Reyna SV; Ensenat D; Peyton KJ; Wang H; Schafer AI; Durante W
FASEB J; 2004 Apr; 18(6):768-70. PubMed ID: 14977877
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell surface antigen 4F2.
Takabe W; Kanai Y; Chairoungdua A; Shibata N; Toi S; Kobayashi M; Kodama T; Noguchi N
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1640-5. PubMed ID: 15178563
[TBL] [Abstract][Full Text] [Related]
9. L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier.
Tomi M; Mori M; Tachikawa M; Katayama K; Terasaki T; Hosoya K
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2522-30. PubMed ID: 15980244
[TBL] [Abstract][Full Text] [Related]
10. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Tanaka S; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Cancer Sci; 2008 Dec; 99(12):2380-6. PubMed ID: 19018776
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells.
Shennan DB; Thomson J
Oncol Rep; 2008 Oct; 20(4):885-9. PubMed ID: 18813831
[TBL] [Abstract][Full Text] [Related]
12. Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors.
Fan X; Ross DD; Arakawa H; Ganapathy V; Tamai I; Nakanishi T
Biochem Pharmacol; 2010 Sep; 80(6):811-8. PubMed ID: 20510678
[TBL] [Abstract][Full Text] [Related]
13. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
[TBL] [Abstract][Full Text] [Related]
14. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration.
Janpipatkul K; Suksen K; Borwornpinyo S; Jearawiriyapaisarn N; Hongeng S; Piyachaturawat P; Chairoungdua A
Cell Signal; 2014 Aug; 26(8):1668-79. PubMed ID: 24726839
[TBL] [Abstract][Full Text] [Related]
16. High expression of L-type amino acid transporter 1 in infiltrating glioma cells.
Nawashiro H; Otani N; Uozumi Y; Ooigawa H; Toyooka T; Suzuki T; Katoh H; Tsuzuki N; Ohnuki A; Shima K; Shinomiya N; Matsuo H; Kanai Y
Brain Tumor Pathol; 2005; 22(2):89-91. PubMed ID: 18095110
[TBL] [Abstract][Full Text] [Related]
17. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo.
de Groot JF; Liu TJ; Fuller G; Yung WK
Cancer Res; 2005 Mar; 65(5):1934-40. PubMed ID: 15753393
[TBL] [Abstract][Full Text] [Related]
18. Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in oral squamous cell carcinoma and its precusor lesions.
Kim DK; Ahn SG; Park JC; Kanai Y; Endou H; Yoon JH
Anticancer Res; 2004; 24(3a):1671-5. PubMed ID: 15274339
[TBL] [Abstract][Full Text] [Related]
19. Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma.
Kobayashi H; Ishii Y; Takayama T
J Surg Oncol; 2005 Jun; 90(4):233-8. PubMed ID: 15906366
[TBL] [Abstract][Full Text] [Related]
20. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]